An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.
The procedure was performed under a HOPE Act research protocol at an NYU Langone Health center the institution said is among the limited number of US transplant centers equipped and approved to perform HOPE lung transplants.
A smartphone image–centered deep learning model showed promise for intraoperative diagnosis and grading of clinical stage IA lung adenocarcinoma, but grade-specific limitations and lack of outcomes data mean the tool remains investigational.
Junior pathologists showed higher mitotic score accuracy and agreement with artificial intelligence assistance in a preliminary single-center reader study